Evidence for binding of the ectodomain of amyloid precursor protein 695 and activated high molecular weight kininogen

Biochimica et Biophysica Acta - General Subjects

Volumn 1571, Issue 3, 2002, Pages 225-238

  Das, Arpita ^a,b   Smalheiser, Neil R ^a   Markaryan, Adam ^a   Kaplan, Arnold ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b PFIZER INC   (United States)

Author keywords

Activated high molecular weight kininogen; Amyloid precursor protein; Binding; Light chain of high molecular weight kininogen; Neuron

Indexed keywords

AMYLOID PRECURSOR PROTEIN; AMYLOID PRECURSOR PROTEIN 695; HIGH MOLECULAR WEIGHT KININOGEN; KININOGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOTINYLATION; BRAIN BLOOD VESSEL; BRAIN CORTEX; CONTROLLED STUDY; IMMUNOPRECIPITATION; IN VITRO STUDY; LASER MICROSCOPY; MEMBRANE; NERVE CELL; NERVE FIBER GROWTH; NERVOUS SYSTEM DEVELOPMENT; NEUROPIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BIOTINYLATION; BRAIN CHEMISTRY; CELL MEMBRANE; FRONTAL LOBE; HUMANS; HYDROGEN-ION CONCENTRATION; KININOGEN, HIGH-MOLECULAR-WEIGHT; NEURONS; NEUROPIL; PEPTIDE FRAGMENTS; PICHIA; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; SODIUM CHLORIDE;

EID: 0037014577     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00256-8     Document Type: Article

References (74)

1. Alzheimer's disease amyloid precursor protein (AβPP): Proteolytic processing, secretases and bA4 amyloid production
2. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
3. The amyloid precursor protein gene: A neuropeptide gene with diverse functions in the central nervous system
4. The biochemistry of Alzheimer's disease
5. Immunocytochemical localization of amyloid precursor protein in rat brain
6. Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia
7. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: Modulation by interleukin-1
8. Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes
9. Intracellular and cell-surface distribution of amyloid precursor protein in cortical astrocytes
10. The beta A4 amyloid protein precursor in human circulation
11. The amyloid precursor protein of Alzheimer's disease is released by human platelets
12. Alzheimer's disease amyloid precursor protein is present in senile plaques and cerebrospinal fluid: Immunohistochemical and biochemical characterization
13. Detection of soluble forms of the beta-amyloid precursor protein in human plasma
14. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
15. Guilt-by-association goes global
16. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o)
17. APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein
18. The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons
19. The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein
20. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein
21. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein
22. PAT1, a microtubule-interacting protein, recognizes the basolateral sorting signal of amyloid precursor protein
23. Binding partners of Alzheimer's disease proteins: Are they physiologically relevant?
24. Regulation of amyloid protein precursor (APP) binding to collagen and mapping of the binding sites on APP and collagen type I
25. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: Evidence for the participation of heparan sulfate proteoglycans
26. Identification of heparin-binding domains in the amyloid precursor protein of Alzheimer's disease by deletion mutagenesis and peptide mapping
27. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan
28. Beta-Amyloid precursor protein binds to the neurite-promoting IKVAV site of laminin
29. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins
30. Neurite outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease
31. The amyloid precursor protein of Alzheimer's disease and the Aβ peptide
32. Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension
33. Interaction between amyloid precursor protein 695 and a light chain sequence in high molecular weight kininogen
34. Bioregulation of kinins: Kallikreins, kininogens, and kininases
35. Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis
36. The intrinsic coagulation/kinin-forming cascade: Assembly in plasma and cell surfaces in inflammation
37. Substance P precursor and kininogen: Their structures, gene organizations, and regulation
38. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: Identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)
39. Immunohistochemical localization of kininogen in rat spinal cord and brain
40. Expression of kininogen mRNAs and plasma kallikrein mRNA by cultured neurons, astrocytes and meningeal cells in the rat brain
41. High-molecular weight kininogen is present in cultured human endothelial cells: Localization, isolation, and characterization
42. The effect of high molecular weight kininogen on neutrophil adhesion to polymer surfaces
43. Neutrophil adhesion on surfaces preadsorbed with high molecular weight kininogen under well-defined flow conditions
44. High-molecular-weight kininogen preadsorbed to glass surface markedly reduces neutrophil adhesion
45. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor
46. High molecular weight kininogen inhibition of endothelial cell function on biomaterials
47. Human H-kininogen is a ferritin-binding protein
48. Platelet thrombospondin interactions with human high and low molecular weight kininogens
49. Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor
50. Binding of heparin to human high molecular weight kininogen
51. Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin
52. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated A beta protein of Alzheimer's disease
53. Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease
54. Expression, purification, and neurotrophic activity of amyloid precursor protein-secreted forms produced by yeast
55. Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues
56. Defective neurite extension is caused by a mutation in amyloid beta/A4 (A beta) protein precursor found in familial Alzheimer's disease
57. Secreted form of amyloid beta/A4 protein precursor (APP) binds to two distinct APP binding sites on rat B103 neuron-like cells through two different domains, but only one site is involved in neuritotropic activity
58. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
59. Analysis of molecular masses and oligomeric states of protein complexes by blue native electrophoresis and isolation of membrane protein complexes by two-dimensional native electrophoresis
60. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form
61. The structure of postsynaptic densities isolated from dog cerebral cortex: I. Overall morphology and protein composition
62. Expression of human amyloid precursor protein ectodomains in Pichia pastoris: Analysis of culture conditions, purification, and characterization
63. Affinity purification of proteoglycans that bind to the amyloid protein precursor of Alzheimer's disease
64. Differential APP gene expression in rat cerebral cortex, meninges, and primary astroglial, microglial and neuronal cultures
65. Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens: Primary structures of two human prekininogens
66. Surface-induced alterations in the kinetic pathway for cleavage of human high molecular weight kininogen by plasma kallikrein
67. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface
68. The binding of high molecular weight kininogen to cultured human endothelial cells
69. Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells
70. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor
71. Conformation of high molecular weight kininogen: Effects of kallikrein and factor XIa cleavage
72. The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy
73. Identification of the urokinase receptor as an adhesion receptor for vitronectin